Dermata Therapeutics (DRMA) executive compensation, 2026 proxy

Gerald T. Proehl, President and Chief Executive Officer, was paid $472,515 in 2025, up 2% from $461,973 the year before.

Filed
April 17, 2026
Annual meeting
May 27, 2026
Pay year
2025
Named executives
3
CEO total pay
$472,515+2% vs prior year
CEO Base Salary
$280,000Voluntarily reduced to preserve cash
CEO Target Bonus
50%Percentage of base salary
CFO Base Salary
$346,568For fiscal 2025
CDO Base Salary
$366,975For fiscal 2025

How Proehl was paid

$472,515 in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary59%Bonus30%Option awards11%

Named executive officers

ExecutiveTotal
Gerald T. ProehlPresident and Chief Executive Officer$472,515
Kyri K. Van HooseSenior Vice President, Chief Financial Officer$508,535
Christopher J. Nardo, Ph.D.Senior Vice President, Chief Development Officer$537,105

What changed and why

  • $473KGerald T. Proehl earned total compensation of $472,515 in fiscal 2025, representing a slight increase from $461,973 in fiscal 2024.
  • $140KMr. Proehl's 2025 bonus of $140,000 is deferred to preserve cash until a certain financing amount is achieved.
  • Named Executive Officers received annual base salary increases effective January 1, 2026, to adjust compensation levels.
  • Employment agreements provide specified severance payments and benefit reimbursements upon termination without cause or resignation for good reason.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.